Download Files:
SX 011
SKU
HY-108646-Get quote
Category Reference compound
Tags Inflammation/Immunology, JNK;p38 MAPK, MAPK/ERK Pathway
Products Details
Product Description
– SX 011 is a p38 inhibitor with IC50s of 9 nM and 90 nM against p38α and p38β, respectively. SX 011 also inhibits JNK-2 with an IC50 of 100 nM. SX-011 is orally bioavailable[1].
Web ID
– HY-108646
Shipping
– Room temperature
Molecular Formula
– C26H27ClFN3O3
References
– [1]Lee MR, et al. MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein. Curr Med Chem. 2005;12(25):2979-94.|[2]Hynes J Jr, et al. Small molecule p38 inhibitors: novel structural features and advances from 2002-2005. Curr Top Med Chem. 2005;5(10):967-85.
CAS Number
– 309913-42-6
Molecular Weight
– 483.96
SMILES
– O=C(N(C)C)C(C1=CN(C)C2=C1C=C(C(N3CCC(CC4=CC=C(F)C=C4)CC3)=O)C(Cl)=C2)=O
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– JNK;p38 MAPK
Isoform
– JNK1;JNK2;p38α;p38β;p38γ;p38δ
Pathway
– MAPK/ERK Pathway
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.